Raposo Maria Leonor, Pimentel Ana Carolina, Manageiro Vera, Duarte Aida, Caniça Manuela, Vale Filipa F
Faculdade de Ciências, BioISI - Instituto de Biossistemas e Ciências Integrativas, Universidade de Lisboa, Lisbon, Portugal.
Faculty of Pharmacy, Research Institute for Medicines (iMed-ULisboa), Universidade de Lisboa, Lisbon, Portugal.
Front Microbiol. 2025 Apr 1;16:1532950. doi: 10.3389/fmicb.2025.1532950. eCollection 2025.
is a Gram-negative opportunistic pathogen, responsible for nosocomial infections worldwide. In recent years, this microorganism has acquired resistance to various antibiotics, prompting the World Health Organization (WHO) to declare carbapenem-resistant (CRAB) a critical priority microorganism requiring urgent attention and the development of new therapeutic options. Here, we screened for prophages in 158 genomes of , comprising 139 complete genomes from the Bacterial and Viral Bioinformatics Resource Center (BV-BRC), and 19 newly sequenced clinical isolates. Additionally, we conducted phylogenetic analyses of prophages, highlighting their diversity and local clustering. The analyzed genomes harbored at least two prophage regions, resulting in the identification of a total of 950 prophage regions, of which 348 were considered complete prophages through software analysis and manual curation, while the remainder may represent prophage remnants. The complete prophages ranged from 28.6 to 103.9 kbp, with an average GC content of 39%. Based on genomic similarity, only 18 complete prophages were taxonomically classified to the genus . Among all identified complete prophages, we identified 166 genes encoding for putative lysins, while prophage regions that were not considered complete could also harbor putative lysins. These findings highlight the abundance of prophage-encoded lysins in genomes, which are promising therapeutic agents for combating infections, particularly in the face of rising antibiotic resistance.
是一种革兰氏阴性机会致病菌,在全球范围内导致医院感染。近年来,这种微生物已对多种抗生素产生耐药性,促使世界卫生组织(WHO)宣布耐碳青霉烯类(CRAB)为需要紧急关注并开发新治疗方案的关键优先微生物。在此,我们在158个的基因组中筛选前噬菌体,其中包括来自细菌和病毒生物信息学资源中心(BV - BRC)的139个完整基因组以及19个新测序的临床分离株。此外,我们对前噬菌体进行了系统发育分析,突出了它们的多样性和局部聚类。分析的基因组含有至少两个前噬菌体区域,共鉴定出950个前噬菌体区域,其中通过软件分析和人工筛选有348个被认为是完整的前噬菌体,其余的可能代表前噬菌体残余物。完整的前噬菌体长度从28.6到103.9 kbp不等,平均GC含量为39%。基于基因组相似性,只有18个完整的前噬菌体在分类学上被归类到属。在所有鉴定出的完整前噬菌体中,我们鉴定出166个编码假定溶菌酶的基因,而不被认为完整的前噬菌体区域也可能含有假定溶菌酶。这些发现突出了基因组中前噬菌体编码溶菌酶的丰富性,它们是对抗感染的有前景的治疗剂,特别是在面对抗生素耐药性不断上升的情况下。